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Background: Asymmetric dimethyl-arginine (ADMA), an endogenous competitive inhibitor of nitric oxide synthase (NOS), has been demonstrated 
as a cause of endothelial dysfunction and a predictor of adverse cardiac events by a reduced NO bioavailability. Pre-procedural elevated platelet 
activation represents an important prognostic factor in patients undergoing percutaneous coronary intervention (PCI). The aim of this study was to 
correlate ADMA serum levels with platelet reactivity before coronary angioplasty both in patients (pts) treated with a chronic daily dose of 75 mg and 
in those receiving an acute load of 600 mg.
Methods: A total of 67 pts were prospectively enrolled and divided in two groups according to pre-procedural serum ADMA levels measured by high 
performance liquid chromatography (35 pts with ADMA ≤ 0.70 mmol/L (Group A) e 32 pts with ADMA > 0.70 mmol/L (Group B). Platelet inhibition 
was measured by VerifyNow P2Y12 assay and expressed as P2Y12 reaction units (PRU). Patients with pre-procedural PRU < 240 were defined as 
clopidogrel responders.
Results: The mean ADMA concentration was 0.79±0.20 mmol/L in the overall population. Clopidogrel responders (37 pts) showed significantly 
lower ADMA levels compared to patients clopidogrel non responders (30 pts) (0.73±0.14 vs 0.83±0.22 mmol/L, p = 0.021). On the other hand, 
patients with pre-procedural PRU<240 were 54% in Group A and 34% in Group B (p=0.101). In the sub-population receiving 75 mg/die (31 pts), 
mean pre-procedural PRU level was 212±95 in 15 pts of Group A versus 254±76 in 16 pts of Group B (p=0.176); the percentage of clopidogrel-
responders was significantly higher in the group with lower ADMA levels (73% vs 37%, p = 0.045). No differences were observed in patients treated 
with 600 mg loading dose.
Conclusions: This study that demonstrates a correlation between high serum ADMA levels and residual platelet reactivity after clopidogrel 
administration in patients undergoing elective PCI. This association seems stronger in the subgroup receiving 75 mg/die suggesting the necessity of 
a re-loading before PCI especially in patients with higher ADMA concentrations.
